Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GTx makes appointment

This article was originally published in Scrip

Executive Summary

GTx, a US biopharmaceutical company discovering, developing and commercialising small molecules that target hormone pathways to treat cancer, osteoporosis, bone loss and muscle loss, has appointed Dr Michael Brawer executive director of medical affairs and clinical development. Dr Brawer joins from Tokai Pharmaceuticals, where he served as chief medical officer since 2008. From 2006–07, he was interim chief medical officer at Threshold Pharmaceuticals.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC001676

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel